Madison R. Mack
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Madison R. Mack.
Nature Communications | 2017
Jing Feng; Pu Yang; Madison R. Mack; Dariia Dryn; Jialie Luo; Xuan Gong; Shenbin Liu; Landon K. Oetjen; Alexander Zholos; Zhinan Mei; Shijin Yin; Brian S. Kim; Hongzhen Hu
Although both persistent itch and inflammation are commonly associated with allergic contact dermatitis (ACD), it is not known if they are mediated by shared or distinct signaling pathways. Here we show that both TRPA1 and TRPV1 channels are required for generating spontaneous scratching in a mouse model of ACD induced by squaric acid dibutylester (SADBE), a small molecule hapten, through directly promoting the excitability of pruriceptors. TRPV1 but not TRPA1 channels protect the skin inflammation, as genetic ablation of TRPV1 function or pharmacological ablation of TRPV1-positive sensory nerves promotes cutaneous inflammation in the SADBE-induced ACD. Our results demonstrate that persistent itch and inflammation are mediated by distinct cellular and molecular mechanisms in a mouse model of ACD. Identification of distinct roles of TRPA1 and TRPV1 in regulating itch and inflammation may provide new insights into the pathophysiology and treatment of chronic itch and inflammation in ACD patients.Allergic contact dermatitis is associated both with persistent itch and inflammation, but it is not known if these are mediated by shared signaling pathways. The authors show that persistent itch requires both TRPA1 and TRPV1, while TRPV1 has a protective role against skin inflammation in mice.
bioRxiv | 2017
Andrew J. Shepherd; Aaron D. Mickle; Bryan A. Copits; Páll Karlsson; Suraj Kadunganattil; Judith P. Golden; Satya M Tadinada; Madison R. Mack; Simon Haroutounian; Annette D. de Kloet; Vijay K. Samineni; Manouela V. Valtcheva; Lisa A. McIlvried; T. Sheahan; Sanjay Jain; Pradipta Ray; Yuriy M. Usachev; Gregory Dussor; Brian S. Kim; Eric G. Krause; Theodore J. Price; Robert W. Gereau; Durga P. Mohapatra
Peripheral nerve damage initiates a complex series of cellular and structural processes that culminate in chronic neuropathic pain. Our study defines local angiotensin signaling via activation of the Angiotensin II (Ang II) type-2 receptor (AT2R) on macrophages as the critical trigger of neuropathic pain. An AT2R-selective antagonist attenuates neuropathic, but not inflammatory pain hypersensitivity in mice, and requires the cell damage-sensing ion channel transient receptor potential family-A member-1 (TRPA1). Mechanical and cold pain hypersensitivity that are characteristic of neuropathic conditions can be attenuated by chemogenetic depletion of peripheral macrophages and AT2R-null hematopoietic cell transplantation. Our findings show no AT2R expression in mouse or human sensory neurons, rather AT2R expression and activation in macrophages triggers production of reactive oxygen/nitrogen species, which trans-activate TRPA1 on sensory neurons. Our study defines the precise neuro-immune crosstalk underlying nociceptor sensitization at the site of nerve injury. This form of cell-to-cell signaling represents a critical peripheral mechanism for chronic neuropathic pain, and therefore identifies multiple analgesic targets.
Proceedings of the National Academy of Sciences of the United States of America | 2018
Andrew J. Shepherd; Aaron D. Mickle; Judith P. Golden; Madison R. Mack; Carmen M. Halabi; Annette D. de Kloet; Vijay K. Samineni; Brian S. Kim; Eric G. Krause; Robert W. Gereau; Durga P. Mohapatra
Significance Neuropathic pain is a widespread problem that is undermanaged by currently available analgesic drugs. An antagonist of the type II angiotensin II receptor (AT2R) reduces pain behaviors related to neuropathy, suggesting that angiotensin receptor signaling is involved in this pain. We find that AT2R expression is detected not in sensory neurons themselves, but in macrophages that infiltrate the site of nerve injury. Inducible depletion of peripheral macrophages attenuates mechanical and cold pain hypersensitivity related to neuropathy, as does transplantation of AT2R-null bone marrow into an otherwise WT recipient. Our observations provide powerful evidence that neuropathic pain is dependent upon angiotensin signaling, macrophages, and the AT2R-mediated downstream signaling therein. Peripheral nerve damage initiates a complex series of structural and cellular processes that culminate in chronic neuropathic pain. The recent success of a type 2 angiotensin II (Ang II) receptor (AT2R) antagonist in a phase II clinical trial for the treatment of postherpetic neuralgia suggests angiotensin signaling is involved in neuropathic pain. However, transcriptome analysis indicates a lack of AT2R gene (Agtr2) expression in human and rodent sensory ganglia, raising questions regarding the tissue/cell target underlying the analgesic effect of AT2R antagonism. We show that selective antagonism of AT2R attenuates neuropathic but not inflammatory mechanical and cold pain hypersensitivity behaviors in mice. Agtr2-expressing macrophages (MΦs) constitute the predominant immune cells that infiltrate the site of nerve injury. Interestingly, neuropathic mechanical and cold pain hypersensitivity can be attenuated by chemogenetic depletion of peripheral MΦs and AT2R-null hematopoietic cell transplantation. Our study identifies AT2R on peripheral MΦs as a critical trigger for pain sensitization at the site of nerve injury, and therefore proposes a translatable peripheral mechanism underlying chronic neuropathic pain.
Immunity | 2016
Madison R. Mack; Brian S. Kim
The skin barrier is essential for host defense, but how the skin provides protection when the barrier is breached is not well understood. In this issue of Immunity, Gallo and colleagues report that keratinocytes integrate signals from antimicrobial peptides via MAVS signaling to amplify their antiviral immune response.
Cell | 2017
Landon K. Oetjen; Madison R. Mack; Jing Feng; T. Whelan; Haixia Niu; Changxiong J. Guo; Sisi Chen; Anna M. Trier; Amy Xu; Shivani V. Tripathi; Jialie Luo; Xiaofei Gao; Lihua Yang; Samantha L. Hamilton; Peter L. Wang; Jonathan R. Brestoff; Richard Brasington; Andras Schaffer; Frank Brombacher; Chyi-Song Hsieh; Robert W. Gereau; Mark J. Miller; Zhou-Feng Chen; Hongzhen Hu; Steve Davidson; Qin Liu; Brian S. Kim
The Journal of Allergy and Clinical Immunology | 2017
Jing Feng; Jialie Luo; Madison R. Mack; Pu Yang; Feng Zhang; Guan Wang; Xuan Gong; Tao Cai; Zhinan Mei; Brian S. Kim; Shijin Yin; Hongzhen Hu
Journal of Investigative Dermatology | 2017
Landon K. Oetjen; Madison R. Mack; T. Whelan; Changxiong J. Guo; Lihua Yang; Samantha L. Hamilton; Peter L. Wang; Haixia Niu; Jing Feng; Amy Xu; Shivani V. Tripathi; Jialie Luo; Jonathan R. Brestoff; A. Shaffer; Chyi-Song Hsieh; Robert W. Gereau; Mark J. Miller; Hongzhen Hu; S. Davidson; Qin Liu; Brian S. Kim
The Journal of Allergy and Clinical Immunology | 2018
Landon K. Oetjen; Madison R. Mack; Jing Feng; T. Whelan; Haixia Niu; Changxiong J. Guo; Sisi Chen; Anna M. Trier; Amy Xu; Shivani V. Tripathi; Jialie Luo; Xiaofei Gao; Lihua Yang; Samantha L. Hamilton; Peter L. Wang; Jonathan R. Brestoff; Richard Brasington; Andras Schaffer; Frank Brombacher; Chyi-Song Hsieh; Robert W. Gereau; Mark J. Miller; Zhou-Feng Chen; Hongzhen Hu; Steve Davidson; Qin Liu; Brian S. Kim
Journal of Investigative Dermatology | 2018
Madison R. Mack; Jonathan R. Brestoff; Haixia Niu; T. Whelan; Landon K. Oetjen; N. Bodet; F. Wang; Amy Xu; E. Park; D. Margolis; W. Yokoyama; Brian S. Kim
Archive | 2017
Jing Feng; Jialie Luo; Madison R. Mack; Pu Yang; Feng Zhang; Guan Wang; Xuan Gong; Tao Cai; Zhinan Mei; Brian S. Kim; Shijin Yin; Hongzhen Hu